| Natco Pharma (BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01018) |
 |
63.35  -0.55 (-0.86%) |
| BSE : Jul 18, 15:54 |
|
63.80  0.00 (0%) |
| NSE : Jul 18, 15:51 |
|
| Open |
64.45 |
Vol |
11,405 |
| Prev. Close |
63.90 |
|
|
|
Intraday |
52 Week |
|
| Highs |
64.45 |
179.40 |
|
| Lows |
61.55 |
61.30 |
|
|
| Open |
63.05 |
Vol |
27,905 |
| Prev. Close |
63.80 |
|
|
|
Intraday |
52 Week |
|
| Highs |
64.75 |
179.90 |
|
| Lows |
62.70 |
0.00 |
|
|
|
BID |
OFFER |
| Price |
63.35 |
65.00 |
| Quantity |
21.00 |
100.00 |
|
|
BID |
OFFER |
| Price |
63.80 |
0.00 |
| Quantity |
67.00 |
0.00 |
|
| Mkt Cap |
177.64 |
| |
* P/E |
4.44 |
| |
Div |
12.00 |
| |
* EPS (TTM) |
14.28 |
| |
B/V: |
78.67 |
| Mkt Lot |
1.00 |
| |
FV |
10.00 |
| |
* EPS: As per stand alone adjusted profit after extra-ordinary items |
|
| Historic Prices & Returns of Natco Pharma |
Compare Price Performance With Peers |
| Price |
1 week |
2 week |
1 month |
3 month |
6 month |
9 month |
1 year |
| BSE |
/ |
NSE |
| 67.35 |
71.00 |
77.85 |
101.45 |
138.00 |
128.40 |
129.65 |
| -5.94% |
-10.77% |
-18.63% |
-37.56% |
-54.09% |
-50.66% |
-51.14% |
| 67.75 |
71.00 |
77.90 |
100.75 |
137.00 |
129.40 |
130.00 |
| -5.83% |
-10.14% |
-18.1% |
-36.67% |
-53.43% |
-50.7% |
-50.92% |
|
Gain/Loss |
|
|
|
| This page Auto Refreshes every 5 minutes |
|
|
|
| |
|
|
|
|
|
| BSE/NSE Notices - Natco Pharma |
| Natco Pharma Limited has informed the Exchange that: Natco's revenues, profits grow over 30%. The details of the same shall be available on the NSE we |
| |
| more... |
| |
|
|
|
| Financials of Natco Pharma |
Quarterly |
Annual
|
| Income Statement |
(Mar '08) |
(Mar '07) |
| Net Sales |
56.79 |
185.88 |
| Other Income |
9.50 |
15.90 |
| PBDIT |
17.76 |
56.18 |
| Net Profit |
12.21 |
30.46 |
|
|
|
| Balance Sheet |
| Total Share Capital |
27.64 |
| Net Worth |
180.14 |
| Total Debt |
76.44 |
| Net Block |
137.58 |
| Investments |
18.46 |
| Net Current Assets |
80.38 |
| Total Assets |
256.56 |
|
|
|
|
|
| Mutual Funds Holding - Natco Pharma |
|
| Scheme Name |
No. of shr |
|
|
| This stock is not held by any Mutual Fund over the last 6 months. |
|
|
|
|
|
|
|
|
| Company Facts - Natco Pharma |
|
|
|
| Registrars |
Venture Capital & Corporate Inv. Ltd.
6-2-913/914, 3rd Floor
Progressive Towers
Khairatabad
|
| Tel : 23322264,23324804 |
| Fax : 23324803 |
| Email : vccil-hyd@yahoo.co.in |
Website :
|
|
|
|
|
|
| Management - Natco Pharma |
| |
| V C Nannapaneni Chairman and Managing director |
| G S Murthy Director |
| B S Bajaj Director |
| Durga Devi Nannapaneni Whole Time Director |
| Rajeev Nannapaneni Director & COO |
| P Bhaskara Narayana Director & C F O |
| Mukul Sarkar Nominee Director |
| Jasti Samba Siva Rao Director |
| |
|
|
Offline
